Login / Signup

CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas.

Kelly N FitzgeraldAndres E QuesadaGottfried von KeudellSandeep RajNatasha E LewisAhmet DoganGilles SallesMaria Lia Palomba
Published in: Leukemia & lymphoma (2021)
Keyphrases
  • cell therapy
  • stem cells
  • mesenchymal stem cells
  • nk cells
  • monoclonal antibody